Evidence map›Paper›PMID 23612016›Full record

ArticleLeukemia2013

Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.

L Bassaganyas, S Beà, G Escaramís, C Tornador, I Salaverria, L Zapata, O Drechsel, P G Ferreira, B Rodriguez-Santiago, J M C Tubio and 10 more

Erratum issuedAbstract readLetter
In one paragraph

Article in Leukemia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Chromoanagenesis Detection in Chronic Lymphocytic Leukemia.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Chromothripsis.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  4. Cancers · 2022
    Article
  5. Insight into the Molecular Basis Underlying Chromothripsis.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Haematologica · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

L Bassaganyas1] Center for Genomic Regulation (CRG), Barcelona, Spain [2] Pompeu Fabra University (UPF) Barcelona, Spain [3] Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain [4] Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
S Beà
G Escaramís
C Tornador
I Salaverria
L Zapata
O Drechsel
P G Ferreira
B Rodriguez-Santiago
J M C Tubio
A Navarro
D Martín-García
C López
A Martínez-Trillos
A López-Guillermo
M Gut
S Ossowski
C López-Otín
E Campo
X Estivill

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromosome AberrationsGenomicsChromosomes, Human, Pair 6HumansLeukemia, Lymphocytic, Chronic, B-CellMiddle AgedPolymorphism, Single Nucleotide

Identifiers

PMID23612016
PMCPMC3865532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.